Reaction

Gastrointestinal Vascular Malformation Haemorrhagic reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 372 reports · 2 co-occurring drugs

As of the last recalculation, Gastrointestinal Vascular Malformation Haemorrhagic appears in 372 FAERS reports alongside 2 co-occurring drug terms. The strongest observed disproportionality signal is RIVAROXABAN (PRR 200.4).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Rivaroxaban	249	200.4	200.6
Iron Sucrose	10	60.3	60.3

Related reactions

Drug Ineffective
Off Label Use
Death
Nausea
Fatigue

Data source: openFDA FAERS. See the OpenPV methodology and limitations.